Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets

被引:199
|
作者
Miranda-Goncalves, Vera [1 ,2 ]
Honavar, Mrinalini [3 ]
Pinheiro, Celine [1 ,2 ,4 ]
Martinho, Olga [1 ,2 ]
Pires, Manuel M.
Pinheiro, Celia
Cordeiro, Michelle [5 ]
Bebiano, Gil [5 ]
Costa, Paulo [6 ]
Palmeirim, Isabel [7 ,8 ]
Reis, Rui M. [1 ,2 ,9 ]
Baltazar, Fatima [1 ,2 ]
机构
[1] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal
[2] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal
[3] Hosp Pedro Hispano, Dept Pathol, Matosinhos, Portugal
[4] Ctr Hosp Porto, Dept Neurosurg, Oporto, Portugal
[5] Hosp Dr Nelio Mendonca, Madeira, Portugal
[6] Ctr Hosp Montijo, Radiotherapy Serv, Barreiro, Setubal, Portugal
[7] Univ Algarve, Regenerat Med Program, Dept Ciencias Biomed & Med, Faro, Portugal
[8] Univ Algarve, Ctr Biomed Mol & Estrutural, IBB Inst Biotechnol & Bioengn, Faro, Portugal
[9] Barretos Canc Hosp, Mol Oncol Res Ctr, Sao Paulo, Brazil
关键词
CD147; CHC; glioblastomas; gliomas; glycolytic metabolism; lactate; monocarboxylate transporters; MALIGNANT GLIOMA; LACTATE TRANSPORT; LUNG-CANCER; TUMOR-CELLS; INHIBITION; CD147; TEMOZOLOMIDE; METABOLISM; GLYCOLYSIS; GROWTH;
D O I
10.1093/neuonc/nos298
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Gliomas exhibit high glycolytic rates, and monocarboxylate transporters (MCTs) play a major role in the maintenance of the glycolytic metabolism through the proton-linked transmembrane transport of lactate. However, their role in gliomas is poorly studied. Thus, we aimed to characterize the expression of MCT1, MCT4, and their chaperone CD 147 and to assess the therapeutic impact of MCT inhibition in gliomas. Methods. MCTs and CD 147 expressions were characterized by immunohistochemistry in nonneoplastic brain and glioma samples. The effect of CHC (MCT inhibitor) and MCT1 silencing was assessed in in vitro and in vivo glioblastoma models. Results. MCT1, MCT4, and CD 147 were overexpressed in the plasma membrane of glioblastomas, compared with diffuse astrocytomas and nonneoplastic brain. CHC decreased glycolytic metabolism, migration, and invasion and induced cell death in U251 cells (more glycolytic) but only affected proliferation in SW1088 (more oxidative). The effectiveness of CHC in glioma cells appears to be dependent on MCT membrane expression. MCT1 downregulation showed similar effects on different glioma cells, supporting CHC as an MCT1 inhibitor. There was a synergistic effect when combining CHC with temozolomide treatment in U251 cells. In the CAM in vivo model, CHC decreased the size of tumors and the number of blood vessels formed. Conclusions. This is the most comprehensive study reporting the expression of MCTs and CD 147 in gliomas. The MCT1 inhibitor CHC exhibited anti-tumoral and anti-angiogenic activity in gliomas and, of importance, enhanced the effect of temozolomide. Thus, our results suggest that development of therapeutic approaches targeting MCT1 may be a promising strategy in glioblastoma treatment.
引用
收藏
页码:172 / 188
页数:17
相关论文
共 50 条
  • [41] SLC transporters as therapeutic targets: emerging opportunities
    Lawrence Lin
    Sook Wah Yee
    Richard B. Kim
    Kathleen M. Giacomini
    Nature Reviews Drug Discovery, 2015, 14 : 543 - 560
  • [42] MicroRNAs as prognostic markers and therapeutic targets in gliomas
    Sufianov, Albert
    Begliarzade, Sema
    Ilyasova, Tatiana
    Liang, Yanchao
    Beylerli, Ozal
    NON-CODING RNA RESEARCH, 2022, 7 (03): : 171 - 177
  • [43] Altered expression of monocarboxylate transporters 1, 2 and 4 in colorectal carcinomas
    Pinheiro, Celine
    Longatto-Filho, Adhemar
    Ferreira, Luisa
    Scapulatempo, Cristovam
    Af Alves, Venancio
    Pellerin, Luc
    Schmitt, Fernando
    Baltazar, Fatima
    VIRCHOWS ARCHIV, 2007, 451 (02) : 325 - 325
  • [44] Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas
    Pinheiro, Celine
    Longatto-Filho, Adhemar
    Scapulatempo, Cristovam
    Ferreira, Luisa
    Martins, Sandra
    Pellerin, Luc
    Rodrigues, Mesquita
    Alves, Venancio A. F.
    Schmitt, Fernando
    Baltazar, Fatima
    VIRCHOWS ARCHIV, 2008, 452 (02) : 139 - 146
  • [45] Expression profile of Monocarboxylate Transporters and Basigin gene products in the mouse cornea
    Maniccia, Randall G.
    Fong, Joseph D.
    Ochrietor, Judith D.
    FASEB JOURNAL, 2016, 30
  • [46] Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas
    Céline Pinheiro
    Adhemar Longatto-Filho
    Cristovam Scapulatempo
    Luísa Ferreira
    Sandra Martins
    Luc Pellerin
    Mesquita Rodrigues
    Venancio A. F. Alves
    Fernando Schmitt
    Fátima Baltazar
    Virchows Archiv, 2008, 452 : 139 - 146
  • [47] Tissue-Specific Expression of Monocarboxylate Transporters during Fasting in Mice
    Schutkowski, Alexandra
    Wege, Nicole
    Stangl, Gabriele I.
    Koenig, Bettina
    PLOS ONE, 2014, 9 (11):
  • [48] RETRACTED: Gene expression analyses to explore the biomarkers and therapeutic targets for gliomas (Retracted Article)
    Wang, Lina
    Wei, Bo
    Hu, Guozhang
    Wang, Le
    Jin, Ying
    Sun, Zhigang
    NEUROLOGICAL SCIENCES, 2015, 36 (03) : 403 - 409
  • [49] Exhausting exercise and tissue-specific expression of monocarboxylate transporters in rainbow trout
    Omlin, Teye
    Weber, Jean-Michel
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2013, 304 (11) : R1036 - R1043
  • [50] Expression and localization of monocarboxylate transporters and sodium/proton exchangers in bovine rumen epithelium
    Graham, C.
    Gatherar, I.
    Haslam, I.
    Glanville, M.
    Simmons, N. L.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2007, 292 (02) : R997 - R1007